Menzies is renowned internationally for its innovative research that utilises the unique competitive advantages Tasmania offers, including our island geography, stable population and our extensive genealogical records.
We are at the forefront in the fight against disease and intensely committed to this global call for action through ongoing advances in research excellence.
We focus on a range of common diseases within the community including Alzheimer’s disease, arthritis, dementia, diabetes, cancer, cardiovascular disease, cystic fibrosis, mental health, multiple sclerosis (MS), osteoporosis, mot or neurone disease, Parkinson’s disease, stroke and renal disease.
Menzies is tackling these diseases head on, bringing us one step closer to the vision of a healthier future.